No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Dornase Alfa is an enzyme used to treat cystic fibrosis, a genetic disorder that affects the lungs and digestive system. It is a recombinant form of human deoxyribonuclease (DNase) that works by breaking down the thick mucus that builds up in the lungs of cystic fibrosis patients. This helps to reduce the number of lung infections and improve breathing. Dornase Alfa is administered through inhalation and is available in both liquid and powder form.
The Dornase Alfa market is composed of pharmaceutical companies that manufacture and distribute the enzyme. These companies are typically involved in the research and development of new treatments for cystic fibrosis, as well as the production and marketing of existing treatments. Some of the major players in the Dornase Alfa market include GlaxoSmithKline, Novartis, Merck, and Genentech. Show Less Read more
